PHARMACEUTICAL COMPOSITION CONTAINING COMPOUND ISOLATED FROM CATALPA OVALTA FOR PREVENTING OR TREATING NEURODEGENERATIVE DISEASES DUE TO DOPAMINE DEFICIENCY

摘要

PURPOSE: A pharmaceutical composition containing 4,9-dihydroxy-α-lapachone(DHAL) for preventing or treating neurodegenerative diseases is provided to activate dopamine synthesis and L-DOPA induction and effectively use in treating or preventing Parkinson disease.;CONSTITUTION: A pharmaceutical composition for treating or preventing neurodegenerative disease due to dopamine deficiency contains pharmaceutically effective amount of 4,9-dihydroxy-α-lapachone(DHAL) and pharmaceutically acceptable carrier. The 4,9-dihydroxy-α-lapachone(DHAL) is extracted from Catalpa ovalta through activity-guided fractionation and isolation.;COPYRIGHT KIPO 2010